Effect of probiotic fermented milk (kefir) on glycemic control and lipid profile in type 2 diabetic patients: a randomized double-blind placebo-controlled clinical trial - PubMed (original) (raw)

Effect of probiotic fermented milk (kefir) on glycemic control and lipid profile in type 2 diabetic patients: a randomized double-blind placebo-controlled clinical trial

Alireza Ostadrahimi et al. Iran J Public Health. 2015 Feb.

Abstract

Background: Diabetes is a global health problem in the world. Probiotic food has anti-diabetic property. The aim of this trial was to determine the effect of probiotic fermented milk (kefir) on glucose and lipid profile control in patients with type 2 diabetes mellitus.

Methods: This randomized double-blind placebo-controlled clinical trial was conducted on 60 diabetic patients aged 35 to 65 years.Patients were randomly and equally (n=30) assigned to consume either probiotic fermented milk (kefir) or conventional fermented milk (dough) for 8 weeks. Probiotic group consumed 600 ml/day probiotic fermented milk containing Lactobacillus casei, Lactobacillus acidophilus and Bifidobacteria and control group consumed 600 ml/day conventional fermented milk.Blood samples tested for fasting blood glucose, HbA1C, triglyceride (TG), total cholesterol, HDL-C and LDL-C at the baseline and end of the study.

Results: The comparison of fasting blood glucose between two groups after intervention was statistically significant (P=0.01). After intervention, reduced HbA1C compared with the baseline value in probiotic fermented milk group was statistically significant (P=0.001), also the HbA1C level significantly decreased in probiotic group in comparison with control group (P=0.02) adjusting for serum levels of glucose, baseline values of HbA1c and energy intake according to ANCOVA model. Serum triglyceride, total cholesterol, LDL-cholesterol and HDL- cholesterol levels were not shown significant differences between and within the groups after intervention.

Conclusion: Probiotic fermented milk can be useful as a complementary or adjuvant therapy in the treatment of diabetes.

Keywords: Diabetes; Glucose; Kefir; Lipid profile; Probiotic fermented milk.

PubMed Disclaimer

Figures

Fig.1:

Fig.1:

Flow chart of the study

Similar articles

Cited by

References

    1. Leahy JL. ( 2005). Pathogenesis of type 2 diabetes mellitus. Arch Med Res, 36 ( 3): 197– 209. - PubMed
    1. Esteghamati A, Gouya MM, Abbasi M, Delavari A, Alikhani S, Alaedini F, et al. ( 2008). Prevalence of Diabetes and Impaired Fasting Glucose in the Adult Population of Iran National Survey of Risk Factors for Non-Communicable Diseases of Iran. Diabetes Care, 31 ( 1): 96– 98. - PubMed
    1. Guarner F, Perdigon G, Corthier Gr, Salminen S, Koletzko B, Morelli L. ( 2005). Should yoghurt cultures be considered probiotic? Br J Nutr, 93 ( 6): 783– 86. - PubMed
    1. Lye H-S, Kuan C-Y, Ewe J-A, Fung W-Y, Liong M-T. ( 2009). The improvement of hypertension by probiotics: effects on cholesterol, diabetes, renin, and phytoestrogens. Int J Mol Sci, 10 ( 9): 3755– 75. - PMC - PubMed
    1. Davari S, Talaei SA, Alaei H. ( 2013). Probiotics treatment improves diabetes-induced impairment of synaptic activity and cognitive function: behavioral and electrophysiological proofs for microbiome-gut-brain axis. Neuroscience, Epub Mar 7. - PubMed

LinkOut - more resources